Early research of the platelet-rich plasma (PRP) combined with core decompression and allogeneic fibula rod support for the treatment of the osteonecrosis of the femoral head
JIANG Liang-bin,LIU Song, YUE Yong-bin, SUN Hai-zhong，WEI Biao-fang
Chinese Journal of Clinical Anatomy ›› 2018, Vol. 36 ›› Issue (1) : 93-97.
Early research of the platelet-rich plasma (PRP) combined with core decompression and allogeneic fibula rod support for the treatment of the osteonecrosis of the femoral head
Objective To investigate the potency of the platelet-rich plasma (PRP) combined with core decompression and allogeneic fibula rod support for the treatment of the osteonecrosis of the femoral head. Methods From July 2014 to May 2017, 26 cases (35 hips) of osteonecrosis of the femoral head were treated with platelet-rich plasma combined with core decompression and allogeneic fibula rod support (PRP group) and 24 cases (32 hips) with core decompression and allogeneic fibula rod support only (control group). At 1, 3，6 months after operation, Patients were followed up and evaluated using Harris hip score、VAS score and radiography. Results All the patients(67 hips) were followed up thoroughly and the follow-up periods were 6 months. At 6 months after operation, the shape of the femoral heads of the PRP groups was good with no deformation and collapse. The location of the top of the allograft fibula rod was perfect with no fibula rod out. The fibula rods made integration with the surrounding bone without infection. Harris score of PRP group before and after treatment increased from 67.82±9.61 to 88.45±6.02, Harris score of control group before and after treatment increased from 69.74±8.26 to 78.36±6.17；VAS score of PRP group before and after treatment increased from 4.6±1.2 to 1.7±1.0, VAS score of control group before and after treatment increased from 4.3±0.9 to 2.3±1.1. There were statistically significant differences in the pre-therapy and post-treatment groups (P<0.05) and there were statistically significant differences in the postoperation between the two groups (P<0.05). Conclusions Use of the platelet-rich plasma (PRP) in clinic can ease hip pain and improve joint function, and it is highly valuable in clinical use．
Platelet-rich plasma / Osteonecrosis of the femoral head / Allogeneic fibula rod / Core decompression
[1] Okazaki S, Nagoya S, Tateda K, et al. Experimental rat model for alcohol-induced osteonecrosis of the femoral head[J]. Int J Exp Pathol, 2013, 94(5):312-319.
[2] Wu Z, Ji C, Li H, et al. Elevated level of membrane microparticles in the disease of steroid-induced vascular osteonecrosis[J]. J Craniofac Surg, 2013, 24(4):1252-1256.
[3] Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head[J]. Clin Orthop Relat Res, 2010, 468(10):2715-2724.
[4] Chen CC， Lin CL， Chen WC， et al． Vascularized iliac bone-grafting for osteonecrosis with segmental collapse of the femoral head[J]． J Bone Joint Surg Am， 2009，91(10): 2390-2394．
[5] Steinberg ME， Hayken GD， Steinberg DR． The“conservative”management of avascular necrosis of the femoral head[M]∥Arlet J， Ficat PR， Hungerford DS， editors．Bone circulation． Baltimore: Williams and Wilkins， 1984: 334-337．
[6] Garrigues GE， Aldridge JM 3rd， Friend JK， et al． Free vascularized fibular grafting for treatment of osteonecrosis of the femoral head secondary to hip dislocation[J]． Microsurgery， 2009， 29(5): 342-345.
[7] Hungerford DS． Treatment of osteonecrosis of the femoral head: everything's new[J]． J Arthroplasty， 2007， 22(4): 91-94．
[8] Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing[J]. Plast Reconstr Surg,2004,114(6):1502-1508.
[9] van den Dolder J, Mooren R, Vloon AP, et al. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells[J]. Tissue Eng, 2006, 12(11):3067-3073.
[10]Kon E, Filardo G, Delcogliano M, et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper’s knee[J]. Injury, 2009, 40(6): 598-603.
[11]Wu W, Chen F, Liu Y,et al. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model[J]. J Oral Maxillofac Surg, 2007, 65(10):1951-1957.
[12Feitosa ML, FadelL, Beltrão-Braga PC, et al.Successful transplant of mesenchymal stem cells in induced osteonecrosis of the ovine femoral head:preliminary results[J]. Acta Cir Bras, 2010, 25(5): 416-422.
[13Marx RE, Carlson ER, Eichstaidt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1998, 85(6): 638-646.
[14] Okuda K, Kawase T, Momose M, et al. Platelet-rich plasma contains high Levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodongtally related cells in vitro[J]. J Periodontol, 2003, 74(6): 849-857.
[15]Landesberg R, Roy M, Glicsman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation[J]. J Oral Maxillofac Surg, 2003, 58(3): 297-300.
[16] Roldán JC, Jepsen S, Miller J, et al. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7[J]. Bone, 2004, 34(1): 80-90.
[17] Weibrich G, Hansen T, Kleis W, et al. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration[J]. Bone, 2004, 34(4): 665-671.
[18]Danesh-Meyer MJ, Filstein MR, Shanaman R. Histological evaluation of sinus augmentation using platelet rich plasma(PRP): a case series[J]. J Int Acad Periodontol, 2001, 3(2): 48-56.
[19]Welbrich G, Kleis WK, Hafner G, et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count[J]. J Craniomaxillofac Surg, 2002, 30(2): 97-102.
[20] Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review[J]. Int J Oral Maxillofac Implants, 2003, 18(1): 93-103.
[21] Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery[J]. Facial Plast Surg, 2002, 18(1): 27-33.
[22]Yazawa M, Ogata H, Kimura A,et al. Basic studies on the bone formation ability by platelet rich plasma in rabbits[J]. J Craniofac Surg, 2004, 15(3): 439-446.
[23] Risau W, Drexler H, Mironov V, et al. Platelet-derived growth factor is angiogenic in vivo[J]. Growth Factors, 1992, 7(4): 261-266.
[24] Kitoh H, Kitakoji T, Tsuchiya H, et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-a preliminary result of three cases[J]. Bone, 2004, 35(4): 892-898.
[25]Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing.Single and synergistic effects on partial thickness porcine skin wounds[J]. J Clin Invest, 1989, 84(2): 640-646.
[26]Okuda K, Kawase T, Momose M, et al. Platelet-rich plasma contains high Levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodongtally related cells in vitro[J]. J Periodontol, 2003, 74(6): 849-857.[27] Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with application in oral and maxillofacial surgery[J]. J Oral Maxillofac Surg, 1997, 55(11): 1294-1299.
[28]Aghaloo TL, Moy PK, Freymiller EG. Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study[J]. J Oral Maxillofac Surg, 2002, 60(10): 1176-1181.
[29]Choi BH, Im CJ, Huh JY, et al. Effect of platelet-rich plasma on bone regeneration in autogenous bone graft[J]. Int J Oral Maxillofac Surg, 2004, 33(1): 56-59.
[30]Kim SG, Kim WK, Park JC, et al. A comparative study of osseointegration of Avana implants in a demineralized freeze-dried bone alone or with platelet-rich plasma[J]. J Oral Maxillofac Surg, 2002, 60(9): 1018-1025.
/
| 〈 |
|
〉 |
